September 2022 FAQs
- What evidence is there for the 5-day maximum with the use of ketorolac?
- What considerations should pharmacists prescribing nirmatrelvir-ritonavir for the treatment of COVID-19 in the outpatient population be aware of?
- What data are available to support switching between thrombopoietin receptor agonists in patients with immune thrombocytopenia?